FAY GBOLO: Open Payments
NPI 1972172344 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 41 payments from 5 companies in 2025. Trend: 2023 $185 · 2024 $486 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 22 | $563 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $171 |
| Gilead Sciences, Inc. | 4 | $96 |
| Mirum Pharmaceuticals, Inc. | 3 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
Products named: REZDIFFRA, XIFAXAN, Livmarli, IQIRVO, Bylvay.
Industry payments across NY — which companies pay providers there.
